HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Age-related decrease in the antiseizure effect of ifenprodil against pentylenetetrazole in mice.

Abstract
The developmental change in the antiseizure effect of ifenprodil against pentylenetetrazole (PTZ) was examined in mice. Ifenprodil (i.p.) significantly increased the latency to seizure induced by PTZ in 7- and 10-day-old mice, but not in 14- or 21-day-old mice. Intracerebroventricular administration of ifenprodil also failed to modify the latency to PTZ-induced seizure in 21-day-old mice. Dizocilpine produced an increase in the latency to PTZ-induced seizure in 7- and 21-day-old mice. In an NMDA receptor binding assay using [3H]dizocilpine, ifenprodil was clearly more potent in inhibiting [3H]dizocilpine binding in a forebrain membrane preparation from 7- rather than 21-day-old mice. These results suggest that the remarkable antiseizure effect of ifenprodil against PTZ in 7-day-old mice may be related to the high proportion of ifenprodil-sensitive NMDA receptors in the brain.
AuthorsM Tsuda, T Suzuki, M Misawa
JournalBrain research. Developmental brain research (Brain Res Dev Brain Res) Vol. 104 Issue 1-2 Pg. 201-4 (Dec 19 1997) ISSN: 0165-3806 [Print] Netherlands
PMID9466723 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anticonvulsants
  • Convulsants
  • Excitatory Amino Acid Antagonists
  • Neuroprotective Agents
  • Piperidines
  • Dizocilpine Maleate
  • ifenprodil
  • Pentylenetetrazole
Topics
  • Aging (physiology)
  • Animals
  • Anticonvulsants (therapeutic use)
  • Convulsants (antagonists & inhibitors)
  • Dizocilpine Maleate (pharmacology)
  • Excitatory Amino Acid Antagonists (therapeutic use)
  • Injections, Intraventricular
  • Male
  • Mice
  • Mice, Inbred Strains
  • Neuroprotective Agents (pharmacology)
  • Pentylenetetrazole (antagonists & inhibitors)
  • Piperidines (therapeutic use)
  • Reaction Time (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: